Magnapharm Poland Sp. z o.o. operates in Poland as a pharmaceutical company focused on commercialization and distribution of healthcare products. The company distributes and supports market access for Rx medicines, OTC medicines, foods for special medical purposes (FSMP), food supplements, medical devices, dermo-cosmetics and cosmetics, including products requiring enhanced controlled distribution and storage. Its service model covers product registration and regulatory support, import, pharmaceutical-grade warehousing, nationwide distribution, and integrated medical and trade marketing, supported by dedicated sales forces across pharmaceutical and medical lines. The company maintains a pharmaceutical wholesale operation with a logistics base located between Warsaw and Lodz, enabling direct service to the wholesale channel and structured cooperation with pharmacy chains and independent pharmacies across Poland, as well as medical promotion addressed to multiple physician specialties (including dermatology, gynecology, pediatrics, gastroenterology, and ophthalmology). Key assets include the controlled-capacity GDP-aligned warehousing and distribution infrastructure and in-house commercial teams spanning marketing, trade marketing, sales, regulatory/compliance, finance, and HR. The business portfolio includes established partner-originator brands and products commercialized in Poland, with brand examples including Fervex, Efferalgan, Upsarin, Xyzal, Zyrtec, and selected specialty products (including oncology and hospital segment products). Strategically, the company positions itself as an integrated local platform for international and regional partners, combining regulatory capability, compliant distribution, and in-market demand generation to scale healthcare brands in Poland.
Headquarters
Ul. Inflancka 4
Warsaw; Mazowieckie;
Postal Code: 00-189
Contact Details: Purchase the Magnapharm Poland Sp. z o.o. report to view the information.
Website: http://www.adpharma-ms.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service